![](https://investorshub.advfn.com/uicon/48355.png?cb=1551739062)
Tuesday, August 09, 2022 8:41:30 PM
August 09 2022 - 08:25PM
TipRanks
Share On Facebook
In a report released yesterday, Mara Goldstein from Mizuho Securities maintained a Buy rating on eFFECTOR Therapeutics (EFTR - Research Report), with a price target of $20.00. The company's shares closed yesterday at $0.65.According to TipRanks, Goldstein is a 3-star analyst with an average return of 2.4% and a 36.62% success rate. Goldstein covers the Healthcare sector, focusing on stocks such as Nektar Therapeutics, IN8bio, and Incyte.Currently, the analyst consensus on eFFECTOR Therapeutics is a Strong Buy with an average price target of $26.00.See today’s best-performing stocks on TipRanks >>The company has a one-year high of $40.42 and a one-year low of $0.75.
https://www.tipranks.com/news/blurbs/mizuho-securities-sticks-to-its-buy-rating-for-effector-therapeutics-eftr-2?utm_source=advfn.com&utm_medium=referral
New York Yankees and Duke Basketball
Recent EFTR News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 10:20:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 10:00:03 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/10/2024 01:14:29 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 01:31:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/26/2024 09:40:04 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/26/2024 09:32:17 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/10/2024 01:06:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2024 01:01:34 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/08/2024 01:19:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 01:15:32 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/08/2023 01:31:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/08/2023 01:23:32 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/28/2023 01:18:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2023 01:15:33 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 09:23:57 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/11/2023 08:58:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/11/2023 08:51:02 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/08/2023 08:36:11 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/08/2023 08:25:25 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2023 08:11:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2023 08:08:46 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/04/2023 08:06:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/04/2023 08:02:45 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM